What Vinehealth does

Vinehealth is a UK-based digital health company founded in 2018 that developed an AI-based patient support platform focused exclusively on oncology. The platform enables cancer patients to track symptoms, medication side effects, and treatment adherence, while facilitating communication with care teams and capturing longitudinal real-world patient-reported outcomes data. Underlying capabilities include AI-driven patient support programs and predictive analytics applied to symptom and treatment response patterns. The product surface consisted of a mobile application and accompanying clinical dashboard, designed for integration into pharmaceutical patient support programs and NHS clinical workflows. Validation included collaborations with NHS Trusts and partnerships with six top-10 global pharmaceutical companies, including Novartis, for real-world evidence generation and adherence improvement initiatives.

The company's go-to-market was oriented around B2B enterprise sales to pharmaceutical companies seeking digital tools to support oncology therapeutics, supplemented by NHS-facing collaborations to generate real-world evidence within the UK healthcare system. Pricing was not publicly disclosed and the business operated at seed-stage scale, raising approximately $8.45 million in cumulative funding across rounds from 2019 to 2021, led by Talis Capital at the $5.5 million seed round in December 2021. Other investors included Playfair Capital, Ascension, Avonmore Developments, Entrepreneurs First, KHP MedTech Innovations, VOYAGERS Health-Tech Fund, Wayra UK, the Biomedical Catalyst Fund, and EIT Health. Co-founders Rayna Patel (CEO) and Georgina Kirby (CTO) led the company through its independent phase.

In January 2024, Vinehealth was acquired by Sciensus Ltd., the UK's leading provider of clinical care at home serving 300,000 patients annually across chronic conditions, cancer, and rare diseases in multiple European countries. The acquisition integrated Vinehealth's AI-based patient support platform into Sciensus's broader digital tools, patient support programmes, and cancer care at home portfolio, providing immediate pan-European distribution and access to a large clinical homecare infrastructure that materially expanded the platform's reach beyond its prior UK and planned US footprint.

Name

Vinehealth

Legal name

Vinehealth

Website

https://vinehealth.ai

Company type

Private

Founded year

2018

Operating status

Acquired

Headcount range

11–50 employees

Short description

Vinehealth is a UK-based AI-driven digital health platform founded in 2018 that supports cancer patients through symptom and medication side-effect tracking, serving pharmaceutical companies and NHS Trusts with real-world evidence and adherence programs. Acquired by Sciensus in January 2024.

Ownership category

akta.pro rank

Product category

Digital Health Patient Support Software

SIC

Services-Health Services (8000)

akta.pro primary industry

Oncology Telemedicine Platforms (HLALAGAH)

Keywords

• Digital health platform
• Patient support programs
• Cancer care technology
• Symptom tracking software
• Real-world evidence

Headquarters

HQ city

Burton Upon Trent

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Core offering

Vinehealth is an AI-driven digital health platform that provides cancer patient support programs enabling patients to track symptoms, monitor medication side effects, and communicate with care teams. The platform is delivered to pharmaceutical companies for use within their oncology patient support programs and generates real-world patient outcome data for pharma partners, with deployment extending into the NHS and US markets.

Product overview

Vinehealth is a digital health platform for cancer patients that offers AI-based patient support programs. The company developed mobile applications to help cancer patients track symptoms, medication side effects, and communicate with their care teams. Following its acquisition by Sciensus in January 2024, Vinehealth's offerings became part of Sciensus's broader digital health and patient support portfolio.

Differentiator

Problem solved

Functional benefit

Products and services

• Vinehealth Platform An AI-based digital health platform that provides cancer patient support programs, enabling patients to track symptoms and medication side effects, communicate with care teams, and generating real-world evidence data for pharmaceutical partners. It is delivered primarily through commercial partnerships with global pharmaceutical companies for use within oncology patient support programs.

Quantifiable outcome

• Partnerships with six top-10 global pharmaceutical companies including Novartis, demonstrating pharmaceutical industry validation of the platform.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature1 record

Partnerships

Three partnerships are on record, tiered flagship and core.

• SciensusflagshipStrategic or Co-development Partner · 1 January 2024Sciensus Ltd. acquired Vinehealth in January 2024 to expand its digital health offerings. Post-acquisition, Vinehealth's platform is integrated into Sciensus's portfolio of patient support programmes and clinical homecare services, particularly within cancer care. Sciensus is the UK's leading provider of clinical care at home, serving 300,000 patients annually across chronic conditions and cancer, with operations across multiple European countries.
• NHS Trust collaborationscoreStrategic or Co-development Partner · 6 December 2021Vinehealth participated in collaborations with NHS Trusts, integrating with the UK healthcare system to validate its digital health platform and generate real-world evidence from cancer patient populations within the NHS.
• NovartisflagshipStrategic or Co-development Partner · 3 December 2021Novartis is one of six top-10 global pharmaceutical companies partnered with Vinehealth for AI-based patient support programs. These partnerships were focused on improving patient adherence and generating real-world evidence for pharmaceutical clients.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Carevive Systems: Carevive provides a cancer care management platform for symptom monitoring, patient-reported outcomes, and real-world evidence. It is highly comparable in target customer (oncology providers and pharma) and product functionality (PRO/symptom capture) to Vinehealth.
• Belong.Life: Belong.Life operates a cancer patient community and AI-driven patient engagement app that combines symptom tracking with peer support. It overlaps with Vinehealth on oncology patient support, AI-enabled engagement, and pharma partnerships.
• Kaiku Health: Kaiku Health provides digital symptom monitoring for cancer patients and is widely used in European oncology centers. It is a direct competitor in oncology PRO/symptom monitoring with pharma real-world evidence offerings.
• Medisafe: Medisafe is a digital medication adherence and patient support platform with pharma partnerships. While broader than oncology, it competes in the same patient support / adherence / side-effect tracking category that Vinehealth addresses.
• Noona: Noona is an oncology-focused patient engagement and symptom-tracking platform acquired by Varian (now Siemens Healthineers). It directly competes with Vinehealth by enabling cancer patients to report symptoms and by providing real-world data to pharma and providers.
• Outcomes4Me: Outcomes4Me is an AI-driven cancer patient app providing personalized treatment insights, symptom tracking, and clinical trial matching. It directly overlaps with Vinehealth on AI-enabled oncology patient support and pharma-facing data offerings.
• Voluntis (now Aptar Pharma, Theraxium): Voluntis developed digital therapeutics for chronic conditions including oncology supportive care, partnering with pharma to deliver companion digital tools. Comparable to Vinehealth in serving pharma patient support programs and condition-specific digital interventions.

Broad incumbents

• Biofourmis: Biofourmis is a larger digital health and remote patient monitoring platform with oncology and chronic condition coverage. Comparable to Vinehealth in RPM/symptom monitoring capabilities but operating at a broader portfolio and higher funding scale.
• Medable: Medable is a decentralized clinical trial and patient data platform with significant oncology pharma deployments. It overlaps with Vinehealth in capturing patient-reported outcomes and providing real-world data to pharma.

Emerging players

• Caresense: Caresense is an emerging digital health company applying AI to patient support and remote monitoring. It is comparable to Vinehealth as a smaller, AI-first oncology-adjacent player focused on symptom tracking and adherence.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/VineHealth_

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds5 records

Investors14 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vinehealth